Applications are evaluated based on four criteria:
- Scientific merit
- Innovation
- Clinical and medical impact
- Quality of research environment
Scientific merit
- The validity of the rationale / proposed methodology
- The validity of the expected outcomes
- The validity of the proposed timelines
- The feasibility of completing the proposed work within 18 months
Innovation
- Innovation in design, methodology and objectives
Clinical / medical impact
- Contribution of the Research Project results to increase diagnosis and for clinical and scientific understanding
- Improve disease management or develop novel concepts on immune thrombocytopenia (ITP)
- Relevance of the project to the clinical practice for ITP
- Increase knowledge of SYK inhibition in ITP or other diseases.
QUALITY OF RESEARCH ENVIRONMENT
- Team clinical/scientific expertise and experience
- Qualification of the participants
- Expertise in the academic/clinical research environment